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Background: The development of nonviral gene delivery systems is one of the most intrigu-
ing topics in nanomedicine. However, despite the advances made in recent years, several key 
issues remain unsettled. One of the main problems relates to the difficulty in designing nano-
devices for targeted delivery of genes and other drugs to specific anatomic sites. In this study, 
we describe the development of a novel chitosan nanobubble-based gene delivery system for 
ultrasound-triggered release.
Methods and results: Chitosan was selected for the nanobubble shell because of its low 
toxicity, low immunogenicity, and excellent biocompatibility, while the core consisted of 
perfluoropentane. DNA-loaded chitosan nanobubbles were formed with a mean diameter of 
less than 300 nm and a positive surface charge. Transmission electron microscopic analysis 
confirmed composition of the core-shell structure. The ability of the chitosan nanobubbles to 
complex with and protect DNA was confirmed by agarose gel assay. Chitosan nanobubbles 
were found to be stable following insonation (2.5 MHz) for up to 3 minutes at 37°C. DNA 
release was evaluated in vitro in both the presence and absence of ultrasound. The release of 
chitosan nanobubble-bound plasmid DNA occurred after just one minute of insonation. In vitro 
transfection experiments were performed by exposing adherent COS7 cells to ultrasound in the 
presence of different concentrations of plasmid DNA-loaded nanobubbles. In the absence of 
ultrasound, nanobubbles failed to trigger transfection at all concentrations tested. In contrast, 
30 seconds of ultrasound promoted a moderate degree of transfection. Cell viability  experiments 
demonstrated that neither ultrasound nor the nanobubbles affected cell viability under these 
experimental conditions.
Conclusion: Based on these results, chitosan nanobubbles have the potential to be promising 
tools for ultrasound-mediated DNA delivery.
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Introduction
Gene therapy technology has the potential to offer novel treatments for cancer and other 
diseases caused by gene anomalies. However, one of the most significant  challenges 
faced by the field is the development of safe, nontoxic, and efficient nanodelivery 
systems. Viral vectors represent efficient carriers for gene transduction, but they 
also come with certain limitations, including toxicity and immunogenicity.1 Nonviral 
vectors have consequently attracted much interest as gene carriers to overcome these 
problems, but their transduction efficiency is very low, although many efforts have 
recently been directed towards improving this aspect.2
The use of ultrasound as an external stimulus for gene transfer has also been the 
subject of much investigation. As a physical transfer methodology, ultrasound can 
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circumvent many of the problems associated with gene 
transfer, and its noninvasive nature confers an important 
advantage over other physical methods.3 Ultrasound can be 
strategically used to increase release of active substances 
from microbubbles, ie, gas-filled microspheres. The use of 
microbubbles as gene delivery vehicles and transfection-
enhancing agents is particularly promising.2,4,5 Various 
methods have been proposed for the delivery of genes using 
microbubbles, including: direct physical incorporation of 
DNA into the microbubble shell during fabrication; use of 
cationic lipids incorporated into the microbubble shell to 
bind DNA electrostatically; use of single or multiple layers 
of cationic polymer on the microbubble shell to bind DNA 
electrostatically; covalent linking of DNA-nanoparticle 
carriers; and use of complementary DNA strands to load 
nanoparticles. Most of these microbubble formulations 
have demonstrated high DNA-loading capacity and/or high 
transfection efficiency.
Under the action of ultrasound, microbubbles undergo 
cavitation or produce volumetric oscillations. Microbubble 
cavitation under a certain level of ultrasound pressure can 
transiently modify cell permeability and can create pores 
in the endothelial layer (sonoporation), which aid drug and 
gene delivery. Sonoporation is being studied as an effective 
means of promoting extravasation of large macromolecules, 
such as plasmid DNA, to improve their delivery to tissues 
and targeted release.6 In particular, much research has been 
directed towards combined use of ultrasound and microbub-
bles with the aim of improving transfection efficiency.7,8 
Several formulations of microbubbles with shells composed 
of lipids, proteins, polymers, and surfactants have been 
designed as DNA carriers.9 The combined use of ultrasound 
with DNA-bound bubbles has been found to improve DNA 
transfection in both in vitro and in vivo experiments com-
pared with administration of naked DNA alone.2,10 More 
recently, submicron-sized bubbles, termed nanobubbles, 
have been designed and proposed as a prospective tool for 
gene delivery.11–14
An advantage of nanosized bubbles is their potential 
extravasation capacity and their potential to accumulate 
in pathological tissues via the enhanced permeability and 
retention effect.15,16
In a previous study, we developed DNA-loaded dieth-
ylaminoethyl (DEAE)-dextran nanobubbles as gene delivery 
systems. DEAE-dextran nanobubbles were able to complex 
and transfect DNA.17 In order to design a nanobubble system 
that can be administered in vivo without potential toxicity 
problems related to the presence of DEAE-dextran, here we 
consider a new nanobubble formulation using the known 
biocompatible polysaccharide, chitosan. The aim of the 
current study was to formulate and characterize in vitro 
new nanobubbles composed of a chitosan shell and a per-
fluoropentane core as possible DNA carriers for localized 
ultrasound-mediated gene delivery.
Materials and methods
Materials
Ethanol (96%) was obtained from Carlo Erba (Milan, 
Italy). Soybean lecithin (Epikuron 200®) was kindly gifted 
by Degussa (Hamburg, Germany). Perfluoropentane and 
medium molecular weight chitosan were sourced from 
Sigma-Aldrich (St Louis, MO). Ultrapure water was obtained 
using a 1-800 Millipore system (Molsheim, France).
Cell culture
A COS7 cell line (derived from kidney cells of the  African 
green monkey) was cultured in Dulbecco’s Modif ied 
Eagle’s Medium-High Glucose (PAA, 4061 Pasching, 
Austria)  supplemented with heat-inactivated 10% bovine 
serum (Gibco/BRL, Gaithersburg, MD) and 1% Zell Shield 
 (Minerva Biolabs, Berlin, Germany).
Preparation of pDNA
The pEGFP-C3 plasmid (4.7 kb), encoding green fluorescence 
protein, was transformed in Escherichia coli TOP10 and ampli-
fied in Lysogeny broth media at 37°C overnight. The plasmid 
was purified using the NucleoBond® Xtra plasmid purifica-
tion system (Macherey-Nagel GmbH and Co, KG, Düren, 
 Germany), according to the manufacturer’s protocol. The purity 
of pDNA was certified by the absorbance ratio at OD
260
/OD
280
, 
and its integrity was confirmed by gel electrophoresis. Plasmid 
DNA was stored at −20°C until used.
Synthesis of tetradecylphosphoric acid
To synthesize tetradecylphosphoric acid (C14), 100 mL of 
benzene and 0.26 mol POCl
3
 were introduced into a volumet-
ric flask, and 100 mL of benzene and 0.26 mol tetradecanol 
were then introduced via a funnel and slowly dropped into 
the flask under magnetic stirring for 8 hours. The mixture 
was then evaporated using a rotary evaporator; 2 mL of water 
containing some drops of terz-butilic alcohol, which acts as 
a catalyst to the reaction, was then added to the dry product 
obtained. The resulting solution was separated by washing 
twice with ether in a separating flask. The ether phase was 
then evaporated off and dried under vacuum overnight to 
obtain tetradecylphosphoric acid.
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Determination of chitosan  
surface tension
The surface tension of the chitosan solution in water at pH 
5.5 was measured by the ring method, using a thin platinum 
ring (Kruss K10, Germany).
Preparation of chitosan nanobubbles
Chitosan nanobubbles for DNA complexation were obtained 
using medium molecular weight chitosan (approximately 
170,000 Da, degree of deacetylation 75%–85%) for the shell 
and a perfluorocarbon core. Briefly, to prepare the chitosan 
nanobubbles, an ethanol solution containing Epikuron 200 
(1% w/v) and tetradecylphosphoric acid was added to per-
fluoropentane and ultrapure water under stirring. To obtain 
the nanobubbles, a 2.7% w/v chitosan solution at pH 5.0 was 
added dropwise, whilst the mixture was homogenized using an 
Ultra-Turrax® homogenizer (IKA, Konigswinter, Germany) 
for 3 minutes at 13,000 rpm. The nanobubbles were then puri-
fied by ultra/diafiltration using a TCF2 instrument (Millipore) 
with a membrane cutoff at 100,000. DNA-loaded nanobubbles 
were prepared by adding 300 µL of the nanobubble suspen-
sion to 40 µg of pEGFP-C3 plasmid (4.7 kb, pDNA) encoding 
enhanced green fluorescent protein. The system was incubated 
for 30 minutes and subsequently characterized.
Characterization of nanobubble 
formulation
The average diameters and polydispersity indices of the 
nanobubble formulation were determined by photocorrelation 
spectroscopy using a 90 Plus instrument (Brookhaven, NY) 
at a fixed scattering angle of 90° and a temperature of 25°C. 
Each reported value is the average of ten measurements 
of three different formulation batches. The polydispersity 
index indicates the size distribution within a nanobubble 
population. The electrophoretic mobility and zeta potential 
of each formulation were determined using the 90 Plus 
instrument. For zeta potential determination, samples of the 
formulation were placed into the electrophoretic cell, where 
an electric field of approximately 15 V/cm was applied. Each 
sample was analyzed at least in triplicate. The electrophoretic 
mobility measured was converted into a zeta potential using 
the Smoluchowski equation.
The morphology of each nanobubble formulation was 
determined by transmission electron microscopy performed 
using a Philips CM10 instrument (Philips, Eindhoven, 
The Netherlands). Nanobubble preparations were dropped 
onto a Formvar-coated copper grid and air-dried prior to 
 examination. The morphology of the nanobubbles was 
determined by fluorescent microscopy using a DM2500 Leitz 
instrument. The viscosity of the nanobubbles was determined 
at 25°C and 37°C using a capillary viscometer.
Thermal analysis of nanobubbles
Thermal analysis was carried out using a DSC/7 differential 
scanning calorimeter (Perkin-Elmer, Branford, CT) equipped 
with a TAC 7/DX instrument controller and the Pyris program. 
The instrument was calibrated with indium for melting point 
and heat of fusion before analyses took place. A heating rate 
of 10°C per minute was used in the 25°C–200°C temperature 
range. Standard aluminum sample pans for liquids (Perkin-
Elmer) were used and about 20 mg of nanobubble aqueous 
suspension weighed; an empty aluminum pan was used as 
the reference standard. A chitosan solution was also analyzed 
for comparison purposes. Analyses were carried out under 
nitrogen purge; triple runs were made for each sample.
Ultrasound stability of pDNA-loaded 
nanobubbles
pDNA-loaded nanobubbles were evaluated following their 
exposure to an ultrasound stimulus of oscillation frequency 
2.5 ± 0.1 MHz and an average acoustic pressure distribution 
value of 2.4 ± 0.2 MPa (nominal frequency 50 Hz; nominal 
power 30 W). Each formulation was analyzed before and after 
exposure to ultrasound at 25°C and 37°C for 0.5, 1, 2, 3, and 
5 minutes by morphological analysis of the nanobubble to 
evaluate the integrity of the nanobubble structures.
DNA loading efficiency and complexation 
capacity of nanobubbles
The loading of pDNA was determined spectrophotometrically 
at 260 nm using an ultraviolet-visible spectrophotometer 
(DU 730, Beckman Coulter, Fullerton, CA). Following 
centrifugation of the DNA-loaded nanobubbles, the amount 
of free pDNA in the supernatants was determined using a 
calibration curve created with known amounts of free pDNA 
(5–30 µg/mL). The pDNA loading efficiency of the nano-
bubbles was calculated by subtracting the amount of free 
pDNA from the initial amount added.
Finally, pDNA complexation was evaluated by electro-
phoresis in an agarose gel. Different volumes of nanobubble 
aqueous suspension (6, 8, 10, 12 µL) were incubated with 
4 µg of DNA. DNA-loaded chitosan nanobubbles were then 
loaded into 1% w/v agarose gel and electrophoresis run in 
TAE buffer (40 mM Tris base, 20 mM acetic acid, and 1 mM 
EDTA; pH 8.0) at 60 V for one hour. The gel was then stained 
in a 0.5 µg/mL ethidium bromide solution. For the positive 
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control, a solution of pDNA (0.1 µg/µL) was used. The 
banding pattern was visualized using an ultraviolet transil-
luminator and photographed with a Polaroid camera.
Sodium dodecyl sulfate test
A sodium dodecyl sulfate (SDS) test was carried out to 
evaluate the strength of the pDNA electrostatic interaction, 
whereby the SDS concentration required to displace the 
pDNA from the nanobubbles was assessed. The nanobubble 
formulations were incubated for 3 minutes in increasing 
concentrations of SDS solution (1, 2, 3, 4, and 5%, w/v) 
and then evaluated by electrophoresis analysis: 3% SDS was 
required to displace pDNA completely from the  nanobubbles. 
Further experiments established that SDS does not affect 
nanobubble structure (data not shown). A 3% SDS solution 
was consequently used in subsequent experiments evaluat-
ing the capacity of the nanobubbles to protect pDNA from 
DNase activity.
DNase stability
The capacity of the nanobubbles to protect pDNA from 
DNase activity was evaluated. pDNA (0.12 mg ml) and the 
pDNA-loaded nanobubbles were incubated with DNase I 
(1 U/mL) at 25°C for 15 minutes. Following incubation of 
nanobubbles in 3% SDS solution (w/v) for 3 minutes, the 
nanobubbles were then analyzed by gel electrophoresis for 
the presence of ethidium bromide-bound DNA.
In vitro release of plasmid DNA in 
absence and presence of ultrasound
A chitosan-DNA nanobubble aqueous suspension (1 mL) 
was diluted in 4 mL of phosphate-buffered saline (pH 7.4) 
at 37°C. At defined time intervals, the supernatant was 
collected by centrifugation and chitosan nanobubbles were 
resuspended in 4 mL of fresh buffer. Plasmid DNA released 
into the supernatants was quantified spectrophotometrically 
at 260 nm using an ultraviolet-visible spectrophotometer. To 
evaluate the effect of ultrasound on DNA release, the same 
release experiment was carried out following insonation 
of DNA-loaded chitosan nanobubbles for 10, 30, and 
60 seconds, and for 2, 3 and 5 minutes using an ultrasound 
probe with an oscillation frequency of 2.5 ± 0.1 MHz, and the 
amount of released DNA was quantified (as described 
above).
Determination of hemolytic activity
The hemolytic activity of the chitosan nanobubbles was 
evaluated in human blood. Different percentages (v/v) of 
nanobubble formulations (1.5, 3, 6, 8, and 10%) were added 
to a suspension of erythrocytes (30%, v/v) in phosphate buffer 
at pH 7.4. A solution containing a suspension of erythrocytes 
(30%, v/v) in phosphate buffer pH 7.4 was used as the blank 
condition, to which an excess of ammonium chloride was 
added to obtain complete hemolysis for the hemolytic control. 
Following 90 minutes of incubation at 37°C, the samples were 
centrifuged at 2000 rpm for 10 minutes and the supernatant was 
analyzed using a Lambda 2 Perkin-Elmer spectrophotometer 
at a wavelength of 543 nm. The percentage of hemolysis was 
calculated with respect to the 100% hemolysis control.
Transfection experiments
To test the ability of DEAE:DNA nanobubbles to transfect 
cells, COS7 were seeded at a density of 1 × 104/well in 
96-well plates and grown overnight at 37°C in a  humidified 
5% CO
2
 incubator. Immediately prior to transfection, the 
medium was removed and each well received 100 µL of 
the nanobubble-pDNA complex containing 10, 2, 0.4, or 
0.08 µg/mL pDNA diluted in fresh medium. The wells 
 corresponding to the untreated controls received 100 µL of 
fresh medium. At 24 and 48 hours post-treatment, enhanced 
green fluorescent protein expression was qualitatively evalu-
ated by confocal laser scanning microscopy using an inverted 
Zeiss LSM510 fluorescence microscope (Zeiss, Oberkochen, 
Germany). The same experiments were performed after 
insonation of the cells transfected with nanobubbles for 5, 10, 
15, 30, 60, 90 seconds using an ultrasound probe of oscilla-
tion frequency 2.5 ± 0.1 MHz. The schematic apparatus used 
to insonate the cell plates in the presence of nanobubbles, 
designed in our laboratory, is reported in Figure 1.
Cell plate
US probe
US generator
Water
bath
Figure 1 Schematic apparatus used for transfection experiment in the presence 
of ultrasound.
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Cell viability assay
To test the cytotoxic effects of exposure to pDNA-loaded 
nanobubbles and ultrasound, the viability of COS7 cells was 
determined 48 hours post-transfection using the CellTiter 96 
proliferation assay kit (Promega, Madison, WI), according to 
the manufacturer’s instructions. The effect on cell viability of 
both parameters was expressed as a percentage, by comparing 
the absorbances of samples with the respective controls.
Results
Nanobubbles consisting mainly of a chitosan shell and a 
perfluoropentane core were developed as novel DNA  carriers. 
Chitosan showed a critical micellar concentration of approxi-
mately 0.8 mg/mL, indicating its capacity to localize to the 
interface between the nanobubble perfluoropentane core and 
the aqueous phase. The viscosity of the nanobubble aqueous 
suspension was 4.7 centipoise, which, together with the small 
size of the nanobubbles, renders it suitable for parenteral 
administration.
The average diameters, polydispersity indices, and zeta 
potentials of the nanobubble formulations, before and after 
loading with DNA, are reported in Table 1. The unloaded 
nanobubbles had sizes in the order of magnitude of nano-
meters, with an average diameter of less than 500 nm. After 
incubation of chitosan nanobubbles with DNA, a marked 
decrease in size was observed, indicating that the presence 
of DNA condensed the polymer chains via electrostatic 
interactions, thus confirming plasmid localization.
The positive zeta potential of the chitosan nanobubbles 
decreased after incubation with DNA, indicating the pres-
ence of electrostatic interactions between the positive amino 
chitosan groups and the negative phosphate groups of DNA. 
A further decrease in surface charge could be obtained by 
addition of a greater amount of DNA, but lower zeta poten-
tials might favor the aggregation of nanobubbles and affect 
the physical stability of the nanosuspension. A representative 
transmission electron microscopic image of DNA-loaded 
chitosan nanobubbles is reported in Figure 2, showing a 
well defined core-shell structure with a shell thickness of 
about 60 nm.
Table 1 Physicochemical characteristics of chitosan nanobubbles
Nanobubble  
preparation
Diameter  
mean ± SD (nm)
PI ZP mean ± 
SD (mV)
Chitosan nanobubbles 
without pDNA
412.0 ± 13.8 0.11 +40.9 ± 2.3
Chitosan nanobubbles 
with pDNA
284.2 ± 25.8 0.1 +28.3 ± 1.8
Abbreviations: SD, standard deviation; PI, polydispersity index; ZP, zeta potential.
Figure 2 Transmission electron microscopy image of (A) unloaded and (B) DNA-
loaded chitosan nanobubbles.
Differential scanning calorimetry thermograms of 
chitosan nanobubbles are reported in Figure 3. Two main 
endothermic peaks are present in the differential scanning 
calorimetry profile. The first broad peak at about 70°C is 
related to water evaporation, while the second endother-
mic peak in the 110°C–130°C range is connected to the 
glass transition temperature of water-plasticized chitosan 
 macromolecules.18 Chitosan nanobubbles showed a T
peak
 
at 124.6°C, while the chitosan solution showed a T
peak
 at 
114.7°C. The melting temperatures differed from those of 
a pH 5.0 reference chitosan solution (of the same polymer 
concentration), reflecting a change in the polysaccharide 
matrix in the nanobubble structure.
The stability of chitosan nanobubbles after exposure to 
ultrasound was evaluated. At 25°C, up to 5 minutes of soni-
cation (2.5 MHz) affected neither nanobubble morphology 
nor structure. On the contrary, at 37°C, nanobubbles begin 
to rarefy after 3 minutes and completely disappeared after 
5 minutes of insonation, indicating a decrease in their sta-
bility following exposure to ultrasound that was related to 
the temperature increase. Considering the low boiling point 
of perfluoropentane (approximately 30°C), this component 
might exist as a gas at 37°C; however, the transition might be 
shifted to higher temperature values due to the small sizes of 
the nanobubbles. Furthermore, in the presence of ultrasound, 
the gas core undergoes a conversion from nanodroplet to bub-
ble via a mechanism known as acoustic droplet  vaporization. 
The presence of a central gas core after exposure of the 
chitosan nanobubbles to ultrasound was verified using a 
Visualsonics B-mode imaging instrument at 40 MHz. Indeed, 
chitosan nanobubbles showed good echogenicity (data not 
shown). The pDNA loading efficiency of the nanobubbles 
(determined spectrophotometrically) was approximately 75% 
for a mass of DNA equal to 3.9 × 10−3 µg/µm2. The complex-
ation of DNA with chitosan nanobubbles was confirmed by 
electrophoresis on an agarose gel (Figure 4). It was possible 
to observe a fading of the DNA band, indicating complete 
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Figure 3 Differential scanning calorimetry profile of chitosan solution and chitosan nanobubbles.
1: Naked pDNA 
2: 6 µL nanobubbles + 4 µg pDNA
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Figure 4 Electrophoresis of DNA-loaded chitosan nanobubbles on agarose gel.
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Figure 5 In vitro pDNA release from DNA-loaded chitosan nanobubbles after 
exposure to ultrasound.
complexation of the plasmid with nanobubbles at the tested 
ratio. The amount of DNA loaded onto the nanobubbles was 
not sufficient to saturate all the positive charges presented 
on the bubble surface as confirmed by electrophoresis and 
positive zeta potential values.
Chitosan nanobubbles were able to protect their loaded 
DNA from DNase activity. pDNA could then be displaced 
from the nanobubbles by addition of a 3% SDS solution, as 
shown by a gel retardation assay (data not shown). In the 
in vitro release study, no pDNA release from the nanobubbles 
was observed in the absence of ultrasound, indicating strong 
interaction between the chitosan shell and the pDNA phos-
phate groups. In the presence of ultrasound, no pDNA release 
was observed for sonication times less than one minute 
(Figure 5). For longer sonication times, pDNA started to be 
released from the formulation, as shown in the graph.
Chitosan nanobubbles demonstrated no hemolytic activ-
ity when tested in vitro using red blood cells after 90 minutes 
of incubation at 37°C. For the cell transfection study, the 
experimental setup was tuned using an ultrasound probe of 
oscillation frequency 2.5 ± 0.1 MHz and a cell plate-probe 
distance of 8 cm; 100 µL of nanobubbles was incubated in 
each well in a 96-well plate.
Nonsonified COS7 cells exposed to pDNA-loaded nano-
bubbles failed to show any green fluorescence protein expres-
sion at any of the pDNA concentrations tested (Figure 6B). 
In contrast, triggering pDNA-loaded nanobubbles (carrying 
10 µg/mL of pDNA) with ultrasound for an insonation time 
of 30 seconds improved the transfection efficiency of the 
nanobubbles (Figure 6A). The fluorescence signal obtained 
was not related to autofluorescence phenomena, because no 
fluorescence signal could be detected in nonsonified cells in 
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Figure 7 Effect of ultrasound on COS7 viability.
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Figure 8 COS7 viability assay after incubation with DNA-loaded chitosan 
nanobubbles.
Figure 6 (A) COS7 cells exposed to 30 seconds of insonation in presence of pDNA-loaded nanobubbles carrying 10 µg/mL of pDNA and examined 24 hours post 
transfection by confocal laser scanning microscopy without fixation. (B) COS7 cells treated as in (A) but not sonified. (C) COS7 cells neither exposed to ultrasound nor to 
DNA-loaded nanobubbles.
Note: The upper panels show fluorescence images while the lower panels show merged phase-contrast and fluorescence images.
the absence of nanobubbles (Figure 6C). Further experiments 
are in progress to increase the transfection capacity of the 
formulation in the presence of ultrasound.
Ultrasound did not affect cell viability under these 
experimental conditions, as demonstrated in the cell viability 
assay. In contrast, insonation times longer than 30 seconds 
resulted in a loss of cell viability in COS7 cells transfected 
with pDNA-loaded nanobubbles carrying 10 µg/mL of DNA 
(Figure 7).
The amount of nanobubbles used to deliver 10 µg/mL of 
pDNA did not affect cell viability, as shown by the results of 
the cell viability assay performed on nonsonified COS7 cells 
treated with different concentrations of nanobubble-delivered 
pDNA (Figure 8).
Discussion
Recently, several novel microbubble formulations have 
been developed that aim to improve systemic gene trans-
fection efficiency by loading plasmid DNA or oligonucle-
otides onto the microbubble surface. However, effective in 
vivo gene transfection using microbubble carriers requires 
both a high nucleic acid payload and specific packaging 
systems to promote intracellular delivery and trafficking 
to the nucleus.6
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Of late, nanobubbles have attracted increasing amounts 
of attention because of their capacity to load DNA onto their 
shell; a capacity which holds the potential to enhance circula-
tion times, accumulation in tumor tissues (via the enhanced 
permeation and retention effect) and cellular trafficking.
In a previous study, we developed nanobubbles consisting 
of a diethylaminoethyl-dextran (DEAE-dextran) shell and a 
perfluoropentane core as a DNA carrier. They showed sizes 
smaller than 500 nm, a positive surface charge, and the ability 
to complex and transfect DNA. However, a possible draw-
back of this formulation is its toxic effects at high  dosages. 
To overcome this problem, we designed a new bubble system 
in the nanometer order of magnitude using chitosan as the 
polymeric shell.
We selected chitosan for the bubble shell because this 
polycationic polysaccharide has been increasingly recog-
nized over recent years as providing a safe delivery system 
for genetic material because it boasts low toxicity, low 
immunogenicity, excellent biocompatibility, and a high 
positive charge density.19,20 However, chitosan has the abil-
ity to activate macrophages and to stimulate cytokines.21 
Chitosan enhances the functions of inflammatory cells 
such as polymorphonuclear leukocytes, macrophages, and 
fibroblasts and the stimulation could rely on acetylated 
residues.22 Consequently, its application for parenteral use 
should be carefully investigated. With regard to safety of 
the nanobubbles, no chitosan toxicity was demonstrated in 
in vivo studies at the doses used to prepare our formulation 
(1.35 mg/mL). After intravenous administration in rabbits, 
chitosan levels of 4.5 mg/kg/day caused no effects.21,22 Due 
to its positive charge, it can easily form polyelectrolyte 
complexes with negatively charged nucleotides by means of 
electrostatic interactions. The capacity of chitosan to form a 
bubble shell has previously been investigated and used for 
ultrasound-mediated oxygen delivery via the use of gas-filled 
chitosan nanobubbles.23
In the present study, the formulation was improved to 
obtain smaller systems. In particular, tetradecylphosphoric 
acid was intentionally prepared and added to the formulation 
to produce smaller nanodroplets. This amphiphilic molecule 
can localize to the perfluoropentane-water interface, lowering 
the surface tension.
The choice of perfluoropentane for the nanobubble core 
was due to its already established use in several biomedical 
applications, and because it is a liquid at room temperature 
but a vapor at body temperature. This specific feature per-
mitted us to work with a liquid at room temperature using a 
simple preparation setup. Furthermore, perfluoropentane in 
nanodroplets can be activated by an external stimulus, like 
ultrasound, by means of a mechanism called acoustic droplet 
vaporization, causing the droplet to become a  bubble.24 This 
means that perfluoropentane can be injected in the form 
of liquid droplets, dispersed in an aqueous medium, and 
then converted into bubbles using ultrasound, as shown by 
Rapoport et al.25 In our work, the chitosan formulation is 
referred to as “nanobubbles” for the sake of simplicity, but it 
is important to highlight the fact that before the application 
of ultrasound it would be more correct to use the term “nano-
droplets” when the core is constituted of perfluoropentane 
for describing the system.
Indeed, for small droplets stabilized by polymer shells, 
the Laplace pressure may substantially increase boiling 
 temperature.24 The Laplace pressure is the pressure difference 
between the inside and the outside of a droplet or bubble. 
This effect is caused by the surface tension at the interface 
between the bulk liquid and the droplet liquid.
The Laplace pressure (∆P) is given as:
 ∆ = − =P P P 2
rinside outside
σ
where P
inside
 is the pressure inside a droplet, P
outside
 is the 
pressure outside a droplet, σ is the surface tension, and r is 
droplet radius.
Excessive pressure inside a droplet would result in 
increasing the boiling temperature of perfluoropentane. 
Laplace pressure is reversely proportional to droplet size (as 
indicated in the equation), thus smaller droplets have higher 
boiling temperatures than larger droplets.
Complete complexation of DNA with the formulation was 
achieved, as confirmed by gel retardation assay.  Moreover, 
the strong interaction of DNA with the polycationic nano-
bubble shell protected the loaded DNA from enzymatic 
degradation. The in vitro results showing no release of DNA 
in the absence of ultrasound emphasize the strong interaction 
between the formulation and its DNA cargo and the high 
stability of the system.
The precise ultrasound exposure methods used to facili-
tate gene entry into cells are critical in this regard, and the 
choice of insonation procedure can dramatically alter the 
results.25 It is therefore important that the conditions of 
ultrasound exposure are optimized for their use in ultrasound-
mediated gene delivery.26–29 Preliminary studies were carried 
out to evaluate the experimental parameters to be used in our 
study. The finely tuned conditions identified for ultrasound-
mediated transfection were appropriate for cell safety and 
did not affect cell viability.
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Under the specified conditions, DNA-loaded nanobubbles 
showed the capacity to transfect COS7 cells without affecting 
cell viability. A protocol for obtaining ultrasound-mediated 
gene delivery in vitro was assessed. DNA-loaded chitosan 
nanobubbles showed moderate transfection capacity follow-
ing 30 seconds of insonation. This moderate efficiency might 
be ascribed to possible aggregation phenomena occurring 
amongst nanobubbles at pH 7.4 when the formulation is 
incubated in the cell plate. Modifications of the nanobubble 
formulation are currently being made and tested in order to 
overcome this drawback. Moreover, fluorescent nanobubbles 
will be prepared to investigate cell uptake in the presence 
and absence of ultrasound.
The present study confirmed the feasibility of preparing 
stable and safe nanobubbles using chitosan as the DNA 
carrier. This formulation can be considered as a suitable 
starting point from which improved nanobubble systems 
comprising a chitosan shell can be developed; for example, 
cell targeting units could be linked to the polymeric shell. 
The echogenicity of the formulation might offer the pos-
sibility to visualize DNA-loaded nanobubbles released in 
target tissues. Based on this premise, these new nanobubbles 
hold the potential to provide a multifunctional platform in 
nanomedicine.
Conclusion
The present study reports the generation of novel, small-
sized, positively charged chitosan nanobubbles. These nano-
bubbles show the ability to complex with and protect DNA. 
Their capacity to transfect DNA in vitro was triggered by 
ultrasound. In the absence of ultrasound, none of the tested 
DNA-loaded nanobubble concentrations showed any trans-
fection ability. Following 30 seconds of ultrasound treatment, 
a moderate transfection level was obtained. Shorter sonica-
tion times did not result in successful transfection of the DNA 
cargo into cells, while prolonged sonication times affected 
cell viability under these test conditions. No formulation-
induced cytotoxicity was observed for any of the transfection 
doses used. Chitosan nanobubbles can be considered as an 
interesting tool in the development of ultrasound-responsive 
formulations for targeting DNA delivery.
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